NCT00544687View on ClinicalTrials.gov

Phase I Study of Topical CRx-191 in Normal Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2007

Study Completion Date

November 30, 2007

Conditions
Healthy
Interventions
DRUG

CRx-191

topical (mometasone furoate + nortriptyline HCl)

DRUG

mometasone furoate

topical mometasone furoate

DRUG

nortriptyline HCl

topical nortriptyline HCl

DRUG

Karison® Creme

topical Karison® Creme (clobetasol-17-propinate 0.05%)

DRUG

Vehicle

topical (placebo)

Trial Locations (1)

Unknown

bioskin GmbH, Hamburg

Sponsors

Lead Sponsor

Zalicus
All Listed Sponsors
lead

Zalicus

INDUSTRY

NCT00544687 - Phase I Study of Topical CRx-191 in Normal Healthy Volunteers | Biotech Hunter | Biotech Hunter